Use of conventional synthetic drugs to treat juvenile idiopathic arthritis (JIA) fell by half during 2000-2022, as targeted ...

Panelists emphasized the need for transparency and policy reforms in pharmacy benefit management (PBM) to improve ...

with adalimumab becoming the most commonly used b/tsDMARD. Researchers performed a serial cross-sectional study using ...

Biosimilars offer significant cost-saving potential while expanding patient access, particularly in oncology and immunology.

Treatment with CZP vs ADA may offer more consistent efficacy when used among patients with RA who have elevated RF levels.

The Adalimumab-aacf biosimilar, used to treat a variety of chronic inflammatory diseases including rheumatoid arthritis, psoriasis, and Crohn's disease, has undergone thorough evaluation of a ...

Comorbidities do not significantly impact treatment retention rates among patients with inflammatory RMDs who switch from originator to biosimilar adalimumab.

Sophia Humphreys, PharmD, MHA, BCBBS, of Sutter Health notes that although initial adoption of adalimumab biosimilars remained low in 2023, competitive pricing pressures have already benefited ...

Cyltezo is a prescription drug used to treat certain inflammatory conditions. Learn about the side effects it can cause and how to manage them.

A recent post hoc analysis of the EXXELERATE study revealed that certolizumab pegol (CZP) sustained drug concentration and ...

My gastroenterologist recommended either infliximab or adalimumab-atto. Do you think mercaptopurine causes skin cancer, and if you do, which new prescription would you recommend?

A biologic can target a very specific part of your immune system. For example, the TNF-blocker Humira (adalimumab) works by controlling the effects of tumor necrosis factor (TNF), a protein made by ...